
Sign up to save your podcasts
Or
Sir Peter Ratcliffe, Director of Clinical Research at the Francis Crick Institute, as well as Director of Oxford University’s Target Discovery Institute – has dedicated his life to understanding the body’s molecular-level response to low oxygen levels, or ‘hypoxia’. He received the 2019 Nobel prize for Physiology or Medicine, along with two Americans, William Kaelin of Harvard and Gregg Semenza of Johns Hopkins, for successfully tackling one of physiology’s greatest puzzles - how our bodies sense and adapt so quickly to a lack of oxygen, at high altitude for example, or during sudden exercise.
He talks to Jim about how his early medical career led him into a deeply unfashionable area of medicine that would solve how and why our bodies are so clever at being able to fine tune themselves to keep functioning under a range of conditions. His early ground breaking discoveries may have been initially turned down by a major scientific journal, but he would go on to pave the way for promising new strategies to fight anaemia and many other challenging diseases, most notably cancer.
Producer Adrian Washbourne
4.6
203203 ratings
Sir Peter Ratcliffe, Director of Clinical Research at the Francis Crick Institute, as well as Director of Oxford University’s Target Discovery Institute – has dedicated his life to understanding the body’s molecular-level response to low oxygen levels, or ‘hypoxia’. He received the 2019 Nobel prize for Physiology or Medicine, along with two Americans, William Kaelin of Harvard and Gregg Semenza of Johns Hopkins, for successfully tackling one of physiology’s greatest puzzles - how our bodies sense and adapt so quickly to a lack of oxygen, at high altitude for example, or during sudden exercise.
He talks to Jim about how his early medical career led him into a deeply unfashionable area of medicine that would solve how and why our bodies are so clever at being able to fine tune themselves to keep functioning under a range of conditions. His early ground breaking discoveries may have been initially turned down by a major scientific journal, but he would go on to pave the way for promising new strategies to fight anaemia and many other challenging diseases, most notably cancer.
Producer Adrian Washbourne
5,380 Listeners
381 Listeners
602 Listeners
7,882 Listeners
425 Listeners
112 Listeners
536 Listeners
347 Listeners
122 Listeners
867 Listeners
960 Listeners
289 Listeners
2,063 Listeners
1,049 Listeners
718 Listeners
363 Listeners
398 Listeners
747 Listeners
476 Listeners
684 Listeners
311 Listeners
2,939 Listeners
105 Listeners
69 Listeners
740 Listeners
986 Listeners
466 Listeners
5 Listeners
601 Listeners
124 Listeners
203 Listeners
296 Listeners
15 Listeners